よむ、つかう、まなぶ。
資 料 ３－１ 令和５年度第２回安全技術調査会の概要について (16 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_38341.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会血液事業部会運営委員会（令和5年度第4回 3／13）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
献血後情報に基づく調査の結果PCR陽性となった献血血液
（参考）
Days From blood
donation
to symptom onset
ID
donation
date
Age
Sex
N set Detection rate
[Ct value](IU/mL)
1
2020/7/28
21
M
1
2/9, [44.1-41.4]
1/9, [42.2]
2
2020/11/16
29
M
1
4/9, [40.2-40.9]
7/9, [37.5-41.0]
3
2020/12/22
42
F
1
1/9, [40.2]
2/9, [42.2-44.1]
4
2021/1/11
25
F
1
2/9, [40.4-40.7]
3/9, [39.4-43.8]
5
2021/1/24
49
M
1
2/9, [40.0-40.8]
4/9, [38.0-43.4]
6
2021/2/23
20
M
3
2/9, [40.1-40.6]
4/9, [39.6-40.7]
7
2021/4/7
45
M
0
1/9, [39.1]
2/9, [37.5-41.9]
8
2021/4/23
56
F
2
9/9, [35.6-37.9](433.1)
9/9, [33.6-35.1](453.8)
9
2021/5/5
65
M
0
6/9, [37.4-39.0]
9/9, [35.4-40.2]
10
2021/5/13
50
M
1
9/9, [36.8-39.1]
9/9, [35.8-38.0](82.5)
11
2021/5/21
55
M
0
0/9, [-]
4/9, [37.9-41.7]
12
2021/5/23
50
M
1
7/9, [36.9-40.6]
9/9, [35.0-38.9](113.7)
13
2021/6/19
29
M
1
1/9, [41.5]
3/9, [37.8-39.8]
14
2021/6/23
32
M
2
4/9, [38.0-39.9]
7/9, [36.3-38.9]
15
2021/7/6
60
M
5
8/9, [37.1-38.7]
9/9, [33.9-35.2](519.3)
16
2021/8/2
34
F
1
0/9, [-]
7/9, [37.5-40.4]
17
2021/8/12
55
F
2
2/9, [38.6-39.3]
1/9, [38.6]
18
2021/8/14
50
M
9
1/9, [38.8]
19
2021/8/14
25
M
6
3/9, [40.2-44.7]
20
2021/8/22
51
M
2
2/9, [38.6-39.5]
21
2021/8/27
62
M
5
1/9, [40.0]
22
2021/9/9
55
M
0
2/9, [37.5-39.1]
23
2021/9/10
69
M
4
0/9, [-]
15
N2 set Detection rate
[Ct value](IU/mL)
1/9, [42.7]
2020年3月～2023年11月7日
0/9, [-]
4/9, [38.1-40.3]
総検査数
3860、陽性数 25、
2/9, [38.6-38.9]
陽性血輸血例数 8例
0/9, [-]
3/9, [37.0-39.4]
（参考）
Days From blood
donation
to symptom onset
ID
donation
date
Age
Sex
N set Detection rate
[Ct value](IU/mL)
1
2020/7/28
21
M
1
2/9, [44.1-41.4]
1/9, [42.2]
2
2020/11/16
29
M
1
4/9, [40.2-40.9]
7/9, [37.5-41.0]
3
2020/12/22
42
F
1
1/9, [40.2]
2/9, [42.2-44.1]
4
2021/1/11
25
F
1
2/9, [40.4-40.7]
3/9, [39.4-43.8]
5
2021/1/24
49
M
1
2/9, [40.0-40.8]
4/9, [38.0-43.4]
6
2021/2/23
20
M
3
2/9, [40.1-40.6]
4/9, [39.6-40.7]
7
2021/4/7
45
M
0
1/9, [39.1]
2/9, [37.5-41.9]
8
2021/4/23
56
F
2
9/9, [35.6-37.9](433.1)
9/9, [33.6-35.1](453.8)
9
2021/5/5
65
M
0
6/9, [37.4-39.0]
9/9, [35.4-40.2]
10
2021/5/13
50
M
1
9/9, [36.8-39.1]
9/9, [35.8-38.0](82.5)
11
2021/5/21
55
M
0
0/9, [-]
4/9, [37.9-41.7]
12
2021/5/23
50
M
1
7/9, [36.9-40.6]
9/9, [35.0-38.9](113.7)
13
2021/6/19
29
M
1
1/9, [41.5]
3/9, [37.8-39.8]
14
2021/6/23
32
M
2
4/9, [38.0-39.9]
7/9, [36.3-38.9]
15
2021/7/6
60
M
5
8/9, [37.1-38.7]
9/9, [33.9-35.2](519.3)
16
2021/8/2
34
F
1
0/9, [-]
7/9, [37.5-40.4]
17
2021/8/12
55
F
2
2/9, [38.6-39.3]
1/9, [38.6]
18
2021/8/14
50
M
9
1/9, [38.8]
19
2021/8/14
25
M
6
3/9, [40.2-44.7]
20
2021/8/22
51
M
2
2/9, [38.6-39.5]
21
2021/8/27
62
M
5
1/9, [40.0]
22
2021/9/9
55
M
0
2/9, [37.5-39.1]
23
2021/9/10
69
M
4
0/9, [-]
15
N2 set Detection rate
[Ct value](IU/mL)
1/9, [42.7]
2020年3月～2023年11月7日
0/9, [-]
4/9, [38.1-40.3]
総検査数
3860、陽性数 25、
2/9, [38.6-38.9]
陽性血輸血例数 8例
0/9, [-]
3/9, [37.0-39.4]